Literature DB >> 8035535

[Cardiac arrhythmia and myocardial contraction in opium and ephedrone addiction].

A G Gorgaslidze, M A Saĭfullaeva, M M Kuz'mina, L S Golitsina, A S Smetnev.   

Abstract

Sixty-two patients with opium and ephedrone abuse were studied. They underwent 24-hour Holter monitoring, resting ECG and echocardiography, 18 of them having volumetric loading with polyglucine, 400.0 ml, i.v. Sinus tachycardia was detected in 67.4%, ventricular extrasystole in 4.7%, supraventricular extrasystole with infrequent paroxysms of supraventricular tachycardia in 11.6%. Despite the fact that signs of heart failure were absent and myocardial contractility was normal at rest, echocardiography along with volume loading allow one to reveal in patients some abnormal contractile alterations in the left ventricle. These include its increased volumes, decreased ejection fraction and circulatory shortening rate of myocardial fibers, which suggests that the compensatory potentials of the myocardium are reduced in drug abuse.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8035535

Source DB:  PubMed          Journal:  Kardiologiia        ISSN: 0022-9040            Impact factor:   0.395


  4 in total

1.  Perioperative status and complications in opium addicts in Western rajasthan.

Authors:  Ajay Malviya; Nitin Negi; Manish Mandora; J K Yadav
Journal:  Indian J Surg       Date:  2011-06-11       Impact factor: 0.656

Review 2.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

3.  The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms.

Authors:  Samaneh Nakhaee; Saeedeh Ghasemi; Kimiya Karimzadeh; Nasim Zamani; Samaneh Alinejad-Mofrad; Omid Mehrpour
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-04-17

4.  Is high sensitive-troponin I a reliable biomarker for cardiac injury in methadone toxicity? A prospective cross-sectional study.

Authors:  Hasan Shemirani; Masoumeh Sadeghi; Azadeh Davoudian Dehkordi; Farzad Gheshlaghi
Journal:  BMC Pharmacol Toxicol       Date:  2022-03-23       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.